Oral alitretinoin in congenital ichthyosis: A pilot study shows variable effects and a risk of central hypothyroidism

Acta Dermato-Venereologica

Volumn 92, Issue 3, 2012, Pages 256-257

  Gånemo, Agneta ^a   Sommerlund, Mette ^b   Vahlquist, Anders ^c  

^a LUND UNIVERSITY   (Sweden)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ETRETIN; ISOTRETINOIN; KERATOLYTIC AGENT; THYROTROPIN; THYROXINE;

ADULT; AGED; CASE REPORT; FEMALE; FOLLOW UP; GENE MUTATION; HORMONAL THERAPY; HUMAN; HYPOTHYROIDISM; ICHTHYOSIS; LETTER; MALE; MUTATIONAL ANALYSIS; MYALGIA; PILOT STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ADULT; AGED; FEMALE; HUMANS; HYPOTHYROIDISM; ICHTHYOSIS, LAMELLAR; KERATIN-10; KERATOLYTIC AGENTS; MALE; MIDDLE AGED; MUTATION; PILOT PROJECTS; TRANSGLUTAMINASES; TRETINOIN;

EID: 84859784728     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1302     Document Type: Letter

References (9)

1. Krug M, Oji V, Traupe H, Berneburg M. Ichthyoses - part 2: congenital ichthyoses. J Dtsch Dermatol Ges 2009; 7: 577-588.
2. Gånemo A, Pigg M, Virtanen M, Kukk T, Raudsepp H, Rossman-Ringdahl I, et al. Autosomal recessive congenital ichthyosis in Sweden and Estonia: clinical, genetic and ultrastructural findings in eighty-three patients. Acta Derm Venereol 2003; 83: 24-30.
3. Vahlquist A, Gånemo A, Virtanen M. Congenital ichthyosis: an overview of current and emerging therapies. Acta Derm Venereol 2008; 88: 4-14.
4. Ruzicka T, Lynde CW, Jemec GB, Diepgen T, Berth-Jones J, Coenraads PJ, et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicenter trial. Br J Dermatol 2008; 158: 808-817.
5. Sherman S, Gopa J, Haugen B, Chiu A, Whaley K, Nowlakha P, et al. Central hyothyroidism associated with retinoid X receptor-selective ligands. N Engl J Med 1999; 340: 1075-1079.
6. Aguayo-Leiva IR, Urrutia S, Jaen-Olasolo P. [Response to treatment with oral alitretinoin in patients with chronic hand eczema that is refractory to treatment with potent topical corticosteroids: experience in 15 patients]. Actas Dermosifiliogr 2011; 102: 616-622 (in Spanish).
7. Bissonnette B, Worm M, Gerlach B, Guenther L, Cambazard F, Ruzika T, et al. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema. Br J Dermatol 2010; 162: 420-426.
8. Diepgen T, Pfarr E, Zimmermann T. TOCCATA - effectiveness and tolerability of alitretinoin in chronic hand eczema under daily practice conditions. Acta Derm Venereol 2012; 92; 251-255.
9. Virtanen M, Gedde-Dahl T Jr, Mörk NJ, Leigh I, Bowden PE, Vahlquist A. Phenotypic/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy. Acta Derm Venereol 2001; 81: 163-170.